Hybridoma_Develoment

Confidentiality, technical factors, and timeframe

Your antigen and our skilled technical staff create an ideal combination for your custom antibody requirements. We keep your project in strict confidence. Any hybridoma cell lines that we develop for you remain your exclusive property.

The successful development of hybridoma cell lines producing monoclonal antibodies depends on three factors: 1) the immune system of the host, 2) the antigen, and 3) the assay used to measure antigen-antibody binding.

The project length depends on these factors. Large, highly immunogenic antigens typically result in many hybridoma cell lines from a limited number of immunized mice. Small, highly conserved antigens often require more immunizations, mice, and screening to select an appropriate antibody-producing cell line.

Technical note
For important information about preparing your antigen, see Technical Support.

Contact us.